Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Historical Holders from Q3 2021 to Q3 2025

Symbol
ATXS on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
57,056,058
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
56,014,097
Holdings value
$407,762,856
% of all portfolios
0%
Number of holders
113
Number of buys
50
Number of sells
-49
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 11.5% $47,213,858 6,485,420 Perceptive Advisors LLC 14 Oct 2025
Vestal Point Capital, LP 8.8% $36,079,680 4,956,000 Vestal Point Capital, LP 30 Sep 2025
Magnetar Financial LLC 5.87% $24,112,831 3,312,202 Magnetar Financial LLC 17 Oct 2025
GLAZER CAPITAL, LLC 5.53% $39,250,688 3,155,200 Glazer Capital, LLC 03 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 4.4% $12,704,489 2,457,348 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
Fairmount Funds Management LLC 4% -59% $17,304,917 -$25,421,673 2,377,049 -59.5% Fairmount Funds Management LLC 14 Oct 2025
FMR LLC 2.2% -76.7% $9,112,857 -$28,407,637 1,251,766 -75.7% FMR LLC 31 Oct 2025
INTEGRATED CORE STRATEGIES (US) LLC 0.4% -96% $1,616,895 -$19,770,311 222,101 -92.4% Millennium Management LLC 14 Oct 2025

Institutional Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 56,014,097 $407,762,856 -$10,261,686 $7.28 113
2025 Q2 57,553,753 $309,894,193 -$4,210,865 $5.36 105
2025 Q1 58,322,222 $311,449,455 -$2,818,099 $5.34 112
2024 Q4 58,541,619 $523,363,001 +$15,175,340 $8.94 108
2024 Q3 56,513,523 $622,063,168 +$12,380,808 $11.01 102
2024 Q2 55,579,204 $505,773,414 -$43,969,147 $9.10 100
2024 Q1 57,634,977 $810,618,371 +$319,828,537 $14.08 102
2023 Q4 36,626,752 $281,291,782 +$90,089,493 $7.68 78
2023 Q3 22,981,516 $171,440,766 -$12,708,816 $7.46 68
2023 Q2 24,666,745 $205,474,768 +$6,090,240 $8.33 76
2023 Q1 23,423,158 $311,606,739 +$19,718,386 $13.30 66
2022 Q4 21,794,554 $324,518,327 +$180,101,918 $14.89 60
2022 Q3 9,828,525 $88,847,076 +$41,623,406 $9.04 41
2022 Q2 5,732,278 $17,195,000 -$3,741,817 $3.00 25
2022 Q1 6,210,303 $41,669,000 +$889,657 $6.71 29
2021 Q4 6,093,269 $32,840,000 -$7,416,469 $5.39 29
2021 Q3 7,212,783 $63,765,000 +$63,764,000 $8.84 32